Built-in Blocker: Drug and antidote in the same molecule
October 2, 2006In cases of serious side effects or overdoses of medications, it can be vital to have a fast-acting antidote on hand. This is especially true of drugs that inhibit blood clotting, which are used to prevent and treat thromboses and embolisms, to treat heart attacks, and, in higher doses, in dialysis and in heart surgeries involving a heart-lung machine. Overdoses can lead to life-threatening hemorrhages.
Unfractionated heparin is so far the only blood-clotting inhibitor for which a specific antidote exists. This classic thus continues to be the fallback agent for patients with a high risk of bleeding and in applications requiring rapid reversal of the anticoagulating effect, even though a number of newly developed blood-clotting inhibitors would be more advantageous with regard to their other characteristics.
A research team led by Alexander Heckel, Günter Mayer, and Bernd Pötzsch in Bonn, Germany, has now developed an anticoagulant that brings along its own antidote. Irradiation with UV light activates the part of the molecule that acts as the antidote, which almost immediately halts the blood-clotting inhibition.
This new substance is based on an aptamer that binds to thrombin, a key protein in blood clotting, and blocks it. Aptamers are short, single strands of nucleic acid (DNA) that can bind to another molecule—thrombin in this case—with strength and specificity similar to those of an antibody. In doing this, the aptamer folds into a three-dimensional structure that is perfectly tailored to the structure of the target molecule. The researchers bound another short DNA strand to the thrombin-binding aptamers. This fragment can act as antidote as soon as its “starter” is activated. As long as the antidote hasn’t been activated, the new drug is a highly effective anticoagulant.
If the aptamer’s blood-clotting inhibition needs to be switched off, the drug is irradiated with UV light to activate the starter. The short antidote DNA strand is complementary (the counterpart) to a segment of the thrombin-binding aptamer strand—except for a special, slightly altered nucleotide that acts like an error in the sequence. DNA fragments that are complementary to each other have the tendency to stick together to form a double strand; however, this is initially inhibited by the altered nucleotide.
UV light causes a part of this altered nucleotide to split off, thus making it a normal nucleotide. The sequence error is removed and thus the counterpart can bind tightly to the aptamer strand, forcing the drug into a hairpin-like form. The previous three-dimensional structure of the aptamer is disrupted—and so is its bond to thrombin as well as its anticoagulating effect.
Citation: Alexander Heckel, et al., An Anticoagulant with Light-Triggered Antidote Activity, Angewandte Chemie International Edition 2006, 45, No. 40, 6748–6750, doi: 10.1002/anie.200602346
Source: Angewandte Chemie
-
What are protective effects of anti-ricin A-chain aptamer?
Dec 29, 2008 |
4.5 / 5 (2) |
1
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (31) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
More news stories
Hydrogen from acidic water: Researchers develop potential low cost alternative to platinum for splitting water
A technique for creating a new molecule that structurally and chemically replicates the active part of the widely used industrial catalyst molybdenite has been developed by researchers with the Lawrence Berkeley ...
Feb 09, 2012 |
4.8 / 5 (15) |
21
|
Fool's gold may prove an unlikely alternative to overexploited catalytic materials
Catalytic materials, which lower the energy barriers for chemical reactions, are used in everything from the commercial production of chemicals to catalytic converters in car engines. However, with current catalytic materials ...
Feb 10, 2012 |
4.4 / 5 (8) |
8
|
Research provides octagonal window of opportunity for carbon capture
(PhysOrg.com) -- Filtering carbon dioxide, a greenhouse gas, from factory smokestacks is a necessary, but expensive part of many manufacturing processes. However, a collaborative research team from the National ...
Feb 08, 2012 |
5 / 5 (1) |
5
|
Flexible paper robots
(PhysOrg.com) -- These inexpensive robots can stretch, bend and twist under control, and lift objects up to 120 times their own weight. Being soft, they can apply gentle and even pressure, and adapt to varied ...
Feb 09, 2012 |
5 / 5 (5) |
4
|
New form of hafnium oxide developed
(PhysOrg.com) -- A novel material developed by researchers at the University of Cambridge is opening up new possibilities for next generation electronic and optoelectronic devices, and paving the way for further ...
Feb 07, 2012 |
4.6 / 5 (5) |
4
|
Walney offshore wind farm is world's biggest (for now)
(PhysOrg.com) -- The Walney wind farm on the Irish Sea--characterized by high tides, waves and windy weather--officially opened this week. The farm is treated in the press as a very big deal as the Walney ...
GPS court ruling leaves US phone tracking unclear
A US Supreme Court decision requiring a warrant to place a GPS device on the car of a criminal suspect leaves unresolved the bigger issue of police tracking using mobile phones, legal experts say.
Study finds that anti-diabetic medication can prevent the long-term effects of maternal obesity
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that show that short therapy with the anti-diabetic medication ...
Europe stakes billion-dollar bet on new rocket
A pencil-slim rocket is scheduled to lift into space from South America on Monday, carrying a billion-dollar bet that Europe can grab a juicy slice of the market to place satellites in low orbit.
Netflix settlement trims 14 pct off 4Q earnings
(AP) -- Netflix pressed the rewind button on its fourth-quarter earnings after settling allegations that the video subscription service violated a consumer-privacy law.
Europeans protest controversial Internet pact
Tens of thousands of people marched in protests in more than a dozen European cities Saturday against a controversial anti-online piracy pact that critics say could curtail Internet freedom.